ArticleJournal of pain research2026
Genetically Predicted Intervertebral Disc Degeneration and Risk of Osteoarthritis: A Two-Sample Mendelian Randomization Study with Mediation Analysis of Obesity and Sarcopenia.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic pain related to spinal degeneration and osteoarthritis (OA) represents a major cause of disability worldwide. However, whether intervertebral disc degeneration (IVDD) contributes to OA and related pain burden remains unclear. Objective: To investigate the potential causal relationship between genetically predicted IVDD-related traits and OA risk, and to explore the mediating roles of obesity and sarcopenia. Methods: We conducted a two-sample Mendelian randomization study using genome-wide association study (GWAS) data. IVDD-related genetic instruments were obtained from FinnGen, and OA outcomes included knee osteoarthritis, hip osteoarthritis, and joint replacement. Sensitivity analyses were performed using multiple MR methods. A two-step MR framework was applied to assess mediation effects. Results: Genetically predicted IVDD was associated with an increased risk of HOA (OR = 1.33, 95% CI: 1.20-1.48), THR (OR = 1.37, 95% CI: 1.20-1.56), and KOA (OR = 1.17, 95% CI: 1.09-1.26). Similar associations were observed for lumbar disc prolapse and sciatica, which were consistently linked to higher risks of OA outcomes. Two-step MR analyses indicated that both adiposity-, obesity-, and metabolic-related and sarcopenia-related traits partially mediated these associations. The proportion mediated by adiposity-, obesity-, and metabolic-related traits ranged from approximately 2% to 31%, while sarcopenia-related mediation ranged from 3% to 20%, depending on exposure and outcome pairs. Conclusion: This study provides genetic evidence supporting a potential link between spinal degeneration and chronic pain-related osteoarthritis. Obesity and sarcopenia may serve as partial mediators, highlighting potential targets for prevention and intervention in chronic musculoskeletal pain conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.